Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography

Division of Cardiovascular Diseases, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Annals of the rheumatic diseases (Impact Factor: 10.38). 07/2013; 73(10). DOI: 10.1136/annrheumdis-2013-203314
Source: PubMed


Patients with rheumatoid arthritis (RA) are at increased risk for cardiovascular disease (CVD), although strategies to detect subclinical CVD are poorly characterised. The purpose of this study was to assess myocardial function by speckle-tracking echocardiography strain imaging in patients with RA without known CVD.
Eighty-seven patients with RA selected from a population-based sample underwent echocardiography. Left ventricular (LV) and right ventricular (RV) longitudinal peak systolic strain were measured. A subset of 59 patients with RA was compared with 59 age-, gender- and race-matched subjects with normal echocardiography and no CVD or risk factors.
The mean ± SD age of the patients with RA and the normal patients was 55.7±12.1 and 54.5±12.2 years (p=0.42), respectively, with 45 (76%) women in each group. Global LV strain (-15.7±3.2% vs -18.1±2.4%, p<0.001) and RV strain (-17.9±4.7% vs -20.7±2.4%, p<0.001) was reduced in patients with RA compared with normal patients. Among all 87 patients with RA the mean disease duration and C-reactive protein at echocardiography were 10.0±6.1 years and 3.5±3.7 mg/L, and 74% were seropositive. Adjusted univariate regression analysis demonstrated a significant correlation between global LV strain and RA Health Assessment Questionnaire disability index (p=0.032), and borderline associations with prior use of oral corticosteroids (p=0.062) and methotrexate (p=0.054) after adjustment for age, gender, blood pressure, body mass index, heart rate and LV mass index.
Global longitudinal LV and RV strain is reduced in patients with RA compared with healthy patients. Strain abnormalities correlate with RA disease severity. Strain imaging by echocardiography may detect early myocardial dysfunction in RA.

12 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rheumatic diseases are associated with an increased risk of cardiovascular (CV) mortality attributed to a higher incidence of heart failure (HF) and ischemic heart disease. Although traditional CV risk factors contribute to the increased incidence seen in this population, by themselves they do not account for the increased risk; in fact, obesity and hyperlipidemia may play a paradoxic role. Immune-mediated mechanisms and chronic inflammation likely play a role in the pathogenesis of CV disease in patients with rheumatic diseases. The usual clinical features of ischemic heart disease and HF are less likely to be seen in this patient population.
    Heart Failure Clinics 04/2014; 10(2):339-352. DOI:10.1016/j.hfc.2013.10.003 · 1.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular mortality is high in ESRD, partly driven by sudden cardiac death and recurrent heart failure due to uremic cardiomyopathy. We investigated whether speckle-tracking echocardiography is superior to routine echocardiography in early detection of uremic cardiomyopathy in animal models and whether it predicts cardiovascular mortality in patients undergoing dialysis. Using speckle-tracking echocardiography in two rat models of uremic cardiomyopathy soon (4-6 weeks) after induction of kidney disease, we observed that global radial and circumferential strain parameters decreased significantly in both models compared with controls, whereas standard echocardiographic readouts, including fractional shortening and cardiac output, remained unchanged. Furthermore, strain parameters showed better correlations with histologic hallmarks of uremic cardiomyopathy. We then assessed echocardiographic and clinical characteristics in 171 dialysis patients. During the 2.5-year follow-up period, ejection fraction and various strain parameters were significant risk factors for cardiovascular mortality (primary end point) in a multivariate Cox model (ejection fraction hazard ratio [HR], 0.97 [95% confidence interval (95% CI), 0.95 to 0.99; P=0.012]; peak global longitudinal strain HR, 1.17 [95% CI, 1.07 to 1.28; P<0.001]; peak systolic and late diastolic longitudinal strain rates HRs, 4.7 [95% CI, 1.23 to 17.64; P=0.023] and 0.25 [95% CI, 0.08 to 0.79; P=0.02], respectively). Multivariate Cox regression analysis revealed circumferential early diastolic strain rate, among others, as an independent risk factor for all-cause mortality (secondary end point; HR, 0.43; 95% CI, 0.25 to 0.74; P=0.002). Together, these data support speckle tracking as a postprocessing echocardiographic technique to detect uremic cardiomyopathy and predict cardiovascular mortality in ESRD.
    Journal of the American Society of Nephrology 04/2014; 25(10). DOI:10.1681/ASN.2013070734 · 9.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background The role of inflammation and anti-cyclic citrullinated peptide antibodies (anti-CCP) in the pathogenesis of cardiovascular disease in early rheumatoid arthritis remains unclear. Objectives We investigated how disease activity, anti-CCP status and coronary calcium score in treatment-naive early rheumatoid arthritis impacts left ventricular (LV) systolic function. Methods Fifty-tree patients with steroid- and disease-modifying antirheumatic drug-naive early rheumatoid arthritis were included. Disease activity was scored by the use of the Danish national DANBIO registry (number of swollen joints (NSJ (28)), number of tender joints (NTJ (28)), C-reactive protein (CRP) and Health Assessment Questionnaire (HAQ)). Pain, fatigue, patient and physician global assessment and a composite disease activity score (DAS28-CRP) were assessed by visual analog scales (VAS) 0-100. Results We found LV systolic function by ejection fraction to be 54.1±9.2% and to be non-significant correlated to disease activity (CRP:r=0.07,p=0.64; baseline NSJ:r=-0.13,p=0.33; NTJ:r=-0.08,p=0.58; HAQ:r=0.23,p=0.1; pain VAS:r=-0.05,p=0.74; fatigue VAS:r=0.03,p=0,83; physician global assessment:r=-0.09,p=0.54 and DAS28:r=-0.03,p=0.84). However, by global longitudinal systolic strain (GLS), we found a significant correlation: HAQ:(r=0.29;p=0.037), patient global assessment by VAS:(r=0.35;p=0.011), patient fatigue assessment by VAS:(r=0.3;p=0.03) and DAS28-CRP:(r=0.28;p=0.043); all corrected for relevant confounders. Furthermore, anti-CCP was highly significantly correlated with GLS (r= -0.44;p=0.001) in univariate analysis. In multivariate analysis, it remained significantly correlated (p=0.018). We found a significant difference in GLS in patients with high values of anti-CCP (titers ≥340) compared to patients with anti-CCP titers <340); (-19.9±2.1% vs. -16.4±2.8%;p=0.0001). For patients with high IgM-RF titers results were non-significant. Conclusions We observed a significant correlation between increased disease activity and cardiac function in treatment-naive early rheumatoid arthritis. Disclosure of Interest None declared DOI 10.1136/annrheumdis-2014-eular.1865
    Annals of the Rheumatic Diseases 06/2014; 4(2):79-86. DOI:10.1136/annrheumdis-2014-eular.1865 · 10.38 Impact Factor
Show more